The LiverRisk score: a simple method to assess the presence of fibrosis (scars) within the liver

Liver disease, often dubbed a “silent killer,” poses a major global health threat, progressing unnoticed until reaching life-threatening stages such as cirrhosis or liver cancer. Early detection has long been a challenge, as symptoms usually appear when liver damage is severe. The LiverScreen Consortium’s development of the LiverRisk score marks a transformative advancement in the detection and management of liver disease, offering hope for more timely interventions and improved health outcomes.

Whatch the Video

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132901. The JU receives support from the European Union’s Horizon Europe research and innovation programme and EFPIA, COCIR, MedTech Europe, Vaccines Europe and EuropaBio.

Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

Follow us:

Powered by InnovationActa

Privacy Preference Center